611 related articles for article (PubMed ID: 28098423)
1. Brain-derived neurotrophic factor attenuates doxorubicin-induced cardiac dysfunction through activating Akt signalling in rats.
Hang P; Zhao J; Sun L; Li M; Han Y; Du Z; Li Y
J Cell Mol Med; 2017 Apr; 21(4):685-696. PubMed ID: 28098423
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity.
Fan GC; Zhou X; Wang X; Song G; Qian J; Nicolaou P; Chen G; Ren X; Kranias EG
Circ Res; 2008 Nov; 103(11):1270-9. PubMed ID: 18948619
[TBL] [Abstract][Full Text] [Related]
3. Activation of cardiac TrkB receptor by its small molecular agonist 7,8-dihydroxyflavone inhibits doxorubicin-induced cardiotoxicity via enhancing mitochondrial oxidative phosphorylation.
Zhao J; Du J; Pan Y; Chen T; Zhao L; Zhu Y; Chen Y; Zheng Y; Liu Y; Sun L; Hang P; Du Z
Free Radic Biol Med; 2019 Jan; 130():557-567. PubMed ID: 30472367
[TBL] [Abstract][Full Text] [Related]
4. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
[TBL] [Abstract][Full Text] [Related]
5. C1qTNF-related protein 1 attenuates doxorubicin-induced cardiac injury via activation of AKT.
Chen H; Gao L; Huang Z; Liu Y; Guo S; Xing J; Meng Z; Liang C; Li Y; Yao R; Li L; Zhang Y; Gu H; Liu Y
Life Sci; 2018 Aug; 207():492-498. PubMed ID: 29964055
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide protects H9c2 cardiac cells against doxorubicin-induced cytotoxicity through the PI3K/Akt/FoxO3a pathway.
Liu MH; Zhang Y; He J; Tan TP; Wu SJ; Guo DM; He H; Peng J; Tang ZH; Jiang ZS
Int J Mol Med; 2016 Jun; 37(6):1661-8. PubMed ID: 27081862
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: Plausible roles of p53, MAPK and AKT pathways.
Mantawy EM; Esmat A; El-Bakly WM; Salah ElDin RA; El-Demerdash E
Sci Rep; 2017 Jul; 7(1):4795. PubMed ID: 28684738
[TBL] [Abstract][Full Text] [Related]
8. AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis.
Liu D; Ma Z; Di S; Yang Y; Yang J; Xu L; Reiter RJ; Qiao S; Yuan J
Free Radic Biol Med; 2018 Dec; 129():59-72. PubMed ID: 30172748
[TBL] [Abstract][Full Text] [Related]
9. Chitosan oligosaccharides prevent doxorubicin-induced oxidative stress and cardiac apoptosis through activating p38 and JNK MAPK mediated Nrf2/ARE pathway.
Zhang Y; Ahmad KA; Khan FU; Yan S; Ihsan AU; Ding Q
Chem Biol Interact; 2019 May; 305():54-65. PubMed ID: 30928397
[TBL] [Abstract][Full Text] [Related]
10. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
[TBL] [Abstract][Full Text] [Related]
11. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.
Zhang X; Hu C; Kong CY; Song P; Wu HM; Xu SC; Yuan YP; Deng W; Ma ZG; Tang QZ
Cell Death Differ; 2020 Feb; 27(2):540-555. PubMed ID: 31209361
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway.
Kim KH; Oudit GY; Backx PH
J Pharmacol Exp Ther; 2008 Jan; 324(1):160-9. PubMed ID: 17928571
[TBL] [Abstract][Full Text] [Related]
13. Salidroside improves doxorubicin-induced cardiac dysfunction by suppression of excessive oxidative stress and cardiomyocyte apoptosis.
Wang XL; Wang X; Xiong LL; Zhu Y; Chen HL; Chen JX; Wang XX; Li RL; Guo ZY; Li P; Jiang W
J Cardiovasc Pharmacol; 2013 Dec; 62(6):512-23. PubMed ID: 24072175
[TBL] [Abstract][Full Text] [Related]
14. Diallyl trisulfide suppresses doxorubicin-induced cardiomyocyte apoptosis by inhibiting MAPK/NF-κB signaling through attenuation of ROS generation.
Wen SY; Tsai CY; Pai PY; Chen YW; Yang YC; Aneja R; Huang CY; Kuo WW
Environ Toxicol; 2018 Jan; 33(1):93-103. PubMed ID: 29087013
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptotic pathway via activating the PI3K/Akt pathway.
Jia Y; Zuo D; Li Z; Liu H; Dai Z; Cai J; Pang L; Wu Y
Chem Pharm Bull (Tokyo); 2014; 62(1):45-53. PubMed ID: 24390491
[TBL] [Abstract][Full Text] [Related]
16. Huperzine A Alleviates Oxidative Glutamate Toxicity in Hippocampal HT22 Cells via Activating BDNF/TrkB-Dependent PI3K/Akt/mTOR Signaling Pathway.
Mao XY; Zhou HH; Li X; Liu ZQ
Cell Mol Neurobiol; 2016 Aug; 36(6):915-925. PubMed ID: 26440805
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells.
Guo R; Lin J; Xu W; Shen N; Mo L; Zhang C; Feng J
Int J Mol Med; 2013 Mar; 31(3):644-50. PubMed ID: 23338126
[TBL] [Abstract][Full Text] [Related]
18. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.
Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M
Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523
[TBL] [Abstract][Full Text] [Related]
20. α-Linolenic acid attenuates doxorubicin-induced cardiotoxicity in rats through suppression of oxidative stress and apoptosis.
Yu X; Cui L; Zhang Z; Zhao Q; Li S
Acta Biochim Biophys Sin (Shanghai); 2013 Oct; 45(10):817-26. PubMed ID: 23896563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]